SFRP5 and systemic sclerosis: Reduced expression of SFRP1 and SFRP5 caused by promoter hypermethylation has been documented in skin, oral submucosa, lung, kidney fibrosis, and SSc, while demethylating agents can partially reverse these fibrotic phenotypes.